Post-myocardial infarction mortality patients ventricular premature depolarizations Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study BACKGROUND survivors acute myocardial infarction frequent repetitive ventricular premature depolarizations VPDs ambulatory contribute risk all-cause mortality sudden death beta-blockers antiarrhythmic drug mortality patients VPDs pilot study data aid design multicenter trial amiodarone reduction mortality cardiac arrhythmias patients METHODS RESULTS Seventy-seven patients acute myocardial infarction previous days VPDs/hr runs ventricular tachycardia electrocardiographic recording double-blind fashion amiodarone-to-placebo ratio dose mg/kg/day weeks maintenance dose mg/day reductions intervals response VPD suppression excessive plasma levels toxicity VPD suppression week weeks amiodarone placebo hormone elevation skin reactions side effects amiodarone study drug side effects noncompliance amiodarone patients placebo patients Patients maximum years mean months Arrhythmic death ventricular fibrillation amiodarone patients placebo patients rates all-cause mortality CONCLUSIONS Amiodarone moderate loading maintenance dosages adjustments response plasma levels VPD suppression side effects results effective VPD suppression acceptable levels toxicity 